Zavatta Guido, Vitale Giovanni, Morelli Maria Cristina, Pianta Paolo, Turco Laura, Cappa Federica Mirici, Ravaioli Matteo, Cescon Matteo, Piscaglia Fabio, Altieri Paola, Pagotto Uberto
Division of Endocrinology and Diabetes Prevention and Care, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bologna, Italy.
Intern Emerg Med. 2025 Jan;20(1):139-150. doi: 10.1007/s11739-024-03767-5. Epub 2024 Sep 27.
Liver transplantation (LT) has historically been associated with a high prevalence of osteoporosis, but most of the available data date back to late 1990s-early 2000s with limited sample size. Our aim was to assess the prevalence of bone fragility fractures and contributing factors in a large modern cohort of liver transplant recipients. Retrospective study of 429 consecutive patients receiving liver transplantation from 1/1/2010 to 31/12/2015. Final cohort included 366 patients. Electronic radiological images (lateral views of spine X-rays or Scout CT abdominal scans) performed within 6 months from LT, were blinded reviewed to screen for morphometric vertebral fractures. Symptomatic clinical fragility fractures were recorded from the medical records. Patients with fragility fractures in the cohort were 155/366 (42.3%), with no significant differences between sexes. Most sustained vertebral fractures (145/155, 93.5%), mild or moderate wedges, with severe fractures more frequently observed in women. Multiple vertebral fractures were common (41.3%). Fracture rates were similar across different etiologies of cirrhosis and independent of diabetes or glucocorticoids exposure. Kidney function was significantly worse in women with fractures. Independently of age, sex, alcohol use, eGFR, and etiology of liver disease, low BMI was significantly associated with an increased risk for fractures (adjusted OR 1.058, 95%CI 1.001-1.118, P = 0.046). Our study shows a considerable fracture burden in a large and modern cohort of liver transplant recipients. Given the very high prevalence of bone fractures, a metabolic bone disease screening should be implemented in patients awaiting liver transplantation.
从历史上看,肝移植(LT)一直与骨质疏松症的高患病率相关,但大多数现有数据可追溯到20世纪90年代末至21世纪初,样本量有限。我们的目的是评估大型现代肝移植受者队列中脆性骨折的患病率及其影响因素。对2010年1月1日至2015年12月31日连续接受肝移植的429例患者进行回顾性研究。最终队列包括366例患者。对肝移植后6个月内进行的电子放射图像(脊柱X线侧位片或腹部CT平扫)进行盲法评估,以筛查形态计量学椎体骨折。从病历中记录有症状的临床脆性骨折。该队列中发生脆性骨折的患者为155/366(42.3%),男女之间无显著差异。大多数为椎体骨折(145/155,93.5%),为轻度或中度楔形变,重度骨折在女性中更常见。多发性椎体骨折很常见(41.3%)。不同病因的肝硬化患者骨折发生率相似,且与糖尿病或糖皮质激素暴露无关。骨折女性的肾功能明显更差。独立于年龄、性别、饮酒、估算肾小球滤过率(eGFR)和肝病病因,低体重指数(BMI)与骨折风险增加显著相关(校正比值比1.058,95%置信区间1.001-1.118,P = 0.046)。我们的研究表明,在大型现代肝移植受者队列中存在相当大的骨折负担。鉴于骨折患病率非常高,应对等待肝移植的患者进行代谢性骨病筛查。